Parkman Healthcare Partners’s R1 RCM Inc. Common Stock RCM Stock Holding History

Parkman Healthcare Partners’s Portfolio RCM Stock Details RCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-278,486	Closed	-$5.16M	–	97
2022 Q3	$5.16M	Buy	278,486 +48,073	+21%	+$1.1M	1.47%	21
2022 Q2	$4.83M	Sell	230,413 -112,510	-33%	-$2.55M	1.78%	20
2022 Q1	$9.18M	Buy	342,923 +42,528	+14%	+$1.04M	2.69%	11
2021 Q4	$7.66M	Buy	300,395 +155,395	+107%	+$3.73M	1.69%	23
2021 Q3	$3.19M	Buy	+145,000	New	+$3M	0.81%	36
2020 Q2	–	Sell	-86,492	Closed	-$786K	–	86
2020 Q1	$786K	Sell	86,492 -119,228	-58%	-$1.43M	0.36%	59
2019 Q4	$2.67M	Buy	+205,720	New	+$2.35M	0.77%	45

Other funds holding RCM

NMC

New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parkman Healthcare Partners's RCM Position: Q4 2022 in Review

Parkman Healthcare Partners sold out of R1 RCM Inc. Common Stock (RCM) in Q4 2022, closing a stake of 278,486 shares — an estimated $5.16M sold.

Parkman Healthcare Partners first reported a position in RCM in Q4 2019 and held it in 7 quarters. The position peaked at $9.18M in Q1 2022. 232 funds tracked by Wall St. Rank hold RCM as of Q4 2022.

Parkman Healthcare Partners reported no remaining R1 RCM Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Parkman Healthcare Partners sold 278,486 R1 RCM Inc. Common Stock shares in Q4 2022, an estimated $5.16M.
Parkman Healthcare Partners first reported a position in R1 RCM Inc. Common Stock in Q4 2019 and held it in 7 quarters.
Parkman Healthcare Partners's R1 RCM Inc. Common Stock position peaked at $9.18M in Q1 2022.
232 funds tracked by Wall St. Rank held R1 RCM Inc. Common Stock as of Q4 2022.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.